Your session is about to expire
← Back to Search
Dexamethasone for Chronic Sinusitis
Phase 4
Waitlist Available
Led By Luke Rudmik, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
Dexamethasone added to sinufoam, which is placed in the ethmoid cavity at the completion of endoscopic sinus surgery, will improve sinonasal mucosal healing.
Eligible Conditions
- Chronic Sinusitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: DexamethasoneActive Control1 Intervention
Sinufoam is mixed with dexamethasone and placed within the ethmoid cavity at the completion of sinus surgery
Group II: SalinePlacebo Group1 Intervention
Sinufoam is mixed with saline and placed within the ethmoid cavity at the completion of sinus surgery
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
805 Previous Clinical Trials
883,992 Total Patients Enrolled
2 Trials studying Chronic Sinusitis
154 Patients Enrolled for Chronic Sinusitis
Luke Rudmik, MDPrincipal InvestigatorUniversity of Calgary
2 Previous Clinical Trials
130 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger